Researchers explore potential new target for cancer immunotherapy biorxivpreprint Cancer Immunotherapy Treatment
By Dr. Liji Thomas, MDFeb 27 2023Reviewed by Aimee Molineux *Important notice: bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.
Introduction ICB showed immense promise that has been only partly fulfilled because of its restricted response in a few tumor types and subsets of patients. This has driven intensive research into how tumors respond to ICB depending on their innate mechanisms. Meanwhile, earlier research has shown the crucial regulatory function played by the Hippo pathway in tumor development in mammalian organisms. One of the components of this pathway is the YAP downstream effector molecule, which is a coactivator during the transcription of various genes. It must bind to transcriptional factors such as TEAD-1-4.
What did the study show? The researchers knocked down the YAP gene in cancer cell lines and used these cells to cause cancers in two sets of mice: one immunodeficient and one immunocompetent. Both showed a reduction in tumor growth, by 40% and 60%, respectively. This indicates that YAP regulates the immune microenvironment and thus affects tumor development.
Thus, the level of YAP expression was inversely associated with NLCR5 expression and with APM expression. In other words, NLCR5 is a target gene of YAP/TEAD, and undergoes direct repression when bound by the latter. The end result is the inhibition of MHC-I APM expression via NLCR5.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study supports the concept of atherosclerosis as a T-cell autoimmune disease targeting the arterial wallStudy supports the concept of atherosclerosis as a T-cell autoimmune disease targeting the arterial wall NatureCVR LMU_Muenchen atherosclerosis Tcell autoimmune artery immune immunity disease
Read more »
Using sweat to diagnosis disease: soft microfluidic analysis systems assess health statusUsing sweat to diagnosis disease: soft microfluidic analysis systems assess health status NorthwesternU ScienceMagazine sweat diagnosis disease health
Read more »
People more likely to save money if they have 'nasty' personality, study revealsA study conducted by both Columbia and Colorado University found that those who are more pleasant prioritise spending cash on socialising
Read more »
People Who Think They're Attractive Are Less Likely to Wear Masks, Study SaysPlenty of factors determine whether someone chooses to wear a mask at this stage of the pandemic: their health, their risk tolerance, where they are, who’s around them—and, according to a recent study, how attractive they think they are
Read more »
High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatientsHigh-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients DukeMedSchool Ivermectin COVID19 SARSCoV2 SymptomDuration
Read more »
What is the effect of maternal circulating amino acids on offspring birthweight?Researchers examined the effect of serum levels of 20 amino acids in a mother during pregnancy on offspring birthweight in a two-sample summary data Mendelian randomization framework.
Read more »